ESR1 and neoplasm: In another breast cancer study (n = 110) the median expression of γH2AX was 45% and γH2AX was a marker of poor prognosis including large tumor size, high grade, number of metastatic lymph nodes, expression of HER2- and Ki-67, as well as ER- and PR-negativity (50).